Insider holders · CIK 0001553643
RELMADA THERAPEUTICS, INC. · RLMD
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Sergio TraversaChief Executive Officer | 1,500,000 | — | 1,500,000 | Sep 11, 2026 · 7:30 am EDT | Form 4 |
| Maged ShenoudaChief Financial Officer | 1,000,000 | — | 1,000,000 | Sep 11, 2026 · 7:30 am EDT | Form 4 |
| Paul Edward KellyDirector | 388,483 | — | 388,483 | Dec 11, 2018 · 4:21 pm EST | Form 4 |
| Nabil YazgiDirector | 125,000 | 60,000 | 185,000 | Jan 16, 2015 · 4:25 pm EST | Form 3 |
| Sandesh SethDirector | 123,258 | — | 123,258 | Dec 17, 2015 · 9:38 am EST | Form 4 |
| Shreeram AgharkarDirector | 5,759 | — | 5,759 | Jan 5, 2016 · 4:35 pm EST | Form 4 |
| Charles J CasamentoDirector | 4,200 | — | 4,200 | Dec 16, 2015 · 4:22 pm EST | Form 4 |
| Lisa NolanChief Business Officer | 0 | — | 0 | Dec 17, 2015 · 5:02 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.